Tudor G. Jovin, MD
Cooper University Health Care Titles
- Chairman and Chief of Neurology
- Medical Director, Cooper Neurological Institute
- Stroke Neurologist
Cooper Medical School of Rowan University Titles
- Professor of Neurology
- Professor of Neurosurgery
- Vascular Neurology
- Neurocritical Care
- Neuroendovascular Surgery
German, Romanian, Spanish
Dr. Jovin is an expert in the interventional and non-interventional treatment for the entire spectrum of stroke and cerebrovascular disorders. He was one of the nation’s first interventional neurologists, a medical subspecialty that uses minimally invasive technologies applied from within the vessels to diagnose and treat diseases of the arteries and veins of the head, neck, and spine such as acute stroke, carotid stenosis, intracranial aneurysm, and arteriovenous malformations.
In addition to his clinical experience, Dr. Jovin is known internationally for his research activities. He has served as principal investigator for several international clinical studies including REVASCAT, a randomized trial of endovascular therapy versus medical therapy for acute stroke within eight hours of symptoms onset conducted in Spain, and DAWN, a multicenter, international, randomized trial of endovascular therapy versus medical therapy in the beyond eight-hour time window. Both studies are considered landmark studies in the development of treatments for acute stroke and have been published in the New England Journal of Medicine. He is a member of the executive or steering committees for several multicenter national and international trials, and has participated as site principal investigator or co-investigator in multiple national and international trials.
Additionally, he serves as editorial board member for numerous medical journals. Dr. Jovin has published more than 300 articles in peer-reviewed journals or book chapters. The consequential nature of his research is evidenced by recently published studies that have identified Dr. Jovin as the highest impact author in the neuro-interventional field.
Prior to joining Cooper, Dr. Jovin was a professor of neurology and neurosurgery at the University of Pittsburgh School of Medicine and director of the Center for Neuroendovascular Therapy at the University of Pittsburgh Medical Center (UPMC). At UPMC, he also served as the director of UPMC’s Stroke Institute, one of the leading centers for stroke care, education, and research in the world.
Education & Training
|Medical School||Heinrich Heine University, Dusseldorf, Germany|
|Internship||Internal Medicine - Pennsylvania Hospital, Philadelphia, PA|
|Residency||Neurology - Pennsylvania Hospital, Philadelphia, PA|
|Fellowship||Cerebrovascular/Endovascular - University of Pittsburgh Medical Center, Pittsburgh, PA|
|Fellowship||Neuroendovascular Surgery - University of Pittsburgh Medical Center, Pittsburgh, PA|
- American Academy of Neurology
- American Association of Neurological Surgeons
- American Heart Association – Stroke Council
- American Neurological Association
- American Society of Neuroimaging
- Society of Vascular and Interventional Neurology
- World Stroke Organization
Awards and Honors
- Society of Vascular and Interventional Neurology Pioneering Award, 2015
- Society of Vascular and Interventional Neurology Presidential Service Award, 2015
- Society of Vascular and Interventional Neurology Distinguished Service Award, 2016
- Honorary Member Award, Romanian Society of Stroke, 2017
Ad hoc reviewer New England Journal of Medicine
Ad-hoc reviewer Lancet
Ad-hoc reviewer Journal of the American Medical Association (JAMA)
Ad-hoc reviewer Lancet Neurology
Ad-hoc reviewer Stroke
Ad-hoc reviewer Neurology
Ad-hoc reviewer Annals of Neurology
Ad-hoc reviewer Journal of Neuroimaging
Ad-hoc reviewer Journal of Neurology Neurosurgery and Psychiatry
Ad-hoc reviewer Journal of Endovascular Therapy
Ad-hoc reviewer Neurosurgery
Ad-hoc reviewer Circulation
Ad-hoc reviewer Journal of Neurointerventional Surgery
Ad-hoc reviewer JAMA Neurology
Ad-hoc reviewer NINDS grant submissions
Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A, Román LS, Serena J, Abilleira S, Ribó M, Millán M, Urra X, Cardona P, López-Cancio E, Tomasello A, Castaño C, Blasco J, Aja L, Dorado L, Quesada H, Rubiera M, Hernandez-Pérez M, Goyal M, Demchuk AM, von Kummer R, Gallofré M, Dávalos A; REVASCAT Trial Investigators. Thrombectomy within 8 Hours after Symptom Onset in Ischemic Stroke. N Engl J Med. 2015 Jun 11;372(24):2296-306. doi: 10.1056/NEJMoa1503780. Epub 2015 Apr 17.
Jovin TG. MRI-Guided Intravenous Alteplase for Stroke - Still Stuck in Time. N Engl J Med. 2018 Aug 16;379(7):682-683.
Nogueira RG, Jadhav AP, Haussen DC, Bonafe A, Budzik RF, Bhuva P, Yavagal DR, Ribo M, Cognard C, Hanel RA, Sila CA, Hassan AE, Millan M, Levy EI, Mitchell P, Chen M, English JD, Shah QA, Silver FL, Pereira VM, Mehta BP, Baxter BW, Abraham MG, Cardona P, Veznedaroglu E, Hellinger FR, Feng L, Kirmani JF, Lopes DK, Jankowitz BT, Frankel MR, Costalat V, Vora NA, Yoo AJ, Malik AM, Furlan AJ, Rubiera M, Aghaebrahim A, Olivot JM, Tekle WG, Shields R, Graves T, Lewis RJ, Smith WS, Liebeskind DS, Saver JL, Jovin TG; DAWN Trial Investigators. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct. N Engl J Med. 2018 Jan 4;378(1):11-21.
Goyal M, Menon BK, van Zwam WH, Dippel DW, Mitchell PJ, Demchuk AM, Dávalos A, Majoie CB, van der Lugt A, de Miquel MA, Donnan GA, Roos YB, Bonafe A, Jahan R, Diener HC, van den Berg LA, Levy EI, Berkhemer OA, Pereira VM, Rempel J, Millán M, Davis SM, Roy D, Thornton J, Román LS, Ribó M, Beumer D, Stouch B, Brown S, Campbell BC, van Oostenbrugge RJ, Saver JL, Hill MD, Jovin TG; HERMES collaborators. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016 Feb 18.
Broderick JP, Palesch YY, Demchuk AM, Yeatts SD, Khatri P, Hill lMD< Jauch EC, Jovin TG, Yan B, Silver FL, Von Kummer R, Molina CA, Demaerschalk BM, Dubdzik R, Calark WM, Zaidat OO, Malisch TW, Goyal M, Schonewille WJ, Mazighi M, Engelter ST, Anderson C, Spilker J, Carrozzella J, Ryckborst KJ, Janis LS, Martin RH, Foster LD, Tomsick TA; Interventional Management of Stroke (IMS)III Investigators. Endovascular therapy after Intravenous t-PA versus t-PA alone for stroke. N Engl J Med. 2013 Mar 7;368(10):893-903.
Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Kasner SE, Benesch CG, Sila CA, Jovin TG, Romano JG; Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005 Mar 31;352(13):1305-16.
Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, Roy D, Jovin TG, Willinsky RA, Sapkota BL, Dowlatshahi D, Frei DF, Kamal NR, Montanera WJ, Poppe AY, Ryckborst KJ, Silver FL, Shuaib A, Tampieri D, Williams D, Bang OY, Baxter BW, Burns PA, Choe H, Heo JH, Holmstedt CA, Jankowitz B, Kelly M, Linares G, Mandzia JL, Shankar J, Sohn SI, Swartz RH, Barber PA, Coutts SB, Smith EE, Morrish WF, Weill A, Subramaniam S, Mitha AP, Wong JH, Lowerison MW, Sajobi TT, Hill MD; ESCAPE Trial Investigators.Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015 Mar 12;372(11):1019-30.
Saver JL, Goyal M, Bonafe A, Diener HC, Levy EI, Pereira VM, Albers GW, Cognard C, Cohen DJ, Hacke W, Jansen O, Jovin TG, Mattle HP, Nogueira RG, Siddiqui AH, Yavagal DR, Baxter BW, Devlin TG, Lopes DK, Reddy VK, de Rochemont RD, Singer OC, Jahan R; SWIFT PRIME Investigators. Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke. N Engl J Med. 2015 Apr 17
Jovin TG, Albers GW, Liebeskind DS; STAIR IX Consortium. Stroke Treatment Academic Industry Roundtable: The Next Generation of Endovascular Trials. Stroke. 2016 Oct;47(10):2656-65.
Saver JL, Jahan R, Levy EI, Jovin TG, Baxter B, Nogueira RG, et al; SWIFT Trialists. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, arallel-group, non-inferiority trial. Lancet. 2012;380:1241–1249.
Grants and Research
- RCC Principal Investigator - StrokeNet: The goal of the NINDS Stroke Trials Network is to streamline and accelerate the translation of experimental stroke therapies to clinical application. The Network will consist of a group of Regional Coordinating Centers (RCCs), combining research and clinical expertise with access to significant populations of stroke patients willing to participate in clinical trials. (STN-UP)
- Chair, Executive Committee - AURORA (Analysis of Pooled Data from Randomized StUdies of ThROmbectomy MoRe than 6 hours After Last Known Well
- Global Principal Investigator - DAWN : DWI or CTP Assessment with Clinical Mismatch in the Triage of Wake Up and Late Presenting Strokes Undergoing Neurointervention
- Global Principal Investigator - IN EXTREMIS LASTE (Evaluation of Acute Mechanical Revascularisation in Large Stroke (ASPECTS 0-5) with Large Vessel Occlusion within 6.5 hours after stroke onset or Last Known Well. LArge Stroke Therapy Evaluation)
- Site Co-Investigator - Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial (CREST-2)
- Site Co-Investigator - MISTIE III: A phase III, randomized, open-label, 500-subject clinical trial of minimally invasive surgery plus rt-PA in the treatment of intracerebral hemorrhage.
- Site Co-Investigator - Barrel Trial: Prospective, Multi-Center, Single-Arm Study of the Reverse Medical Barrel Vascular Reconstruction Device (VRD) for Adjunctive Treatment to Embolic Coils for Wide-Neck, Intracranial, Bifurcating/Branching Aneurysms of Middle Cerebral and Basilar Arteries (The BARREL Study)